PG

Procter & Gamble Company
D

PG

Arincen73/100B

Procter & Gamble Company stock buybacks 1990–2027

Procter & Gamble Company spent 1.25B USD buying back its shares in Q1 FY2027, the three months to 30 September 2026, up 0.0% on the same quarter a year before. Procter & Gamble Company spent 5.03B USD buying back its shares over the last twelve months, down 13.5% on the twelve months before. In fiscal year 2026 it spent 5.03B USD, down 22.6% on the year before.

Last updated 5 Nov 2026 · Next report 21 Jan 2027

Stock buybacks

Growth

Fiscal yearPeriod endingStock buybacksGrowthDividends paidFree cash flow
TTM30 Sept 20265.03B-13.47%10.29B15.34B
FY202630 Jun 20265.03B-22.65%10.23B15.15B
FY202530 Jun 20256.50B+29.84%9.87B14.05B
FY202430 Jun 20245.01B-31.92%9.31B16.52B
FY202330 Jun 20237.35B-26.49%9.00B13.79B
FY202230 Jun 202210.00B-9.14%8.77B13.57B
FY202130 Jun 202111.01B+48.67%8.26B15.58B
FY202030 Jun 20207.41B+48.01%7.79B14.33B
FY201930 Jun 20195.00B-28.57%7.50B11.90B
FY201830 Jun 20187.00B+34.59%7.31B11.15B
FY201730 Jun 20175.20B-9.24%7.24B9.37B
FY201630 Jun 20165.73B+24.54%7.44B12.12B
FY201530 Jun 20154.60B-23.33%7.29B10.87B
FY201430 Jun 20146.01B+0.32%6.91B10.11B
FY201330 Jun 20135.99B+48.76%6.52B10.87B
FY201230 Jun 20124.02B-42.83%6.14B9.32B
FY201130 Jun 20117.04B+17.24%5.77B10.02B
FY201030 Jun 20106.00B-5.75%5.46B13.01B
FY200930 Jun 20096.37B-36.60%5.04B11.68B
FY200830 Jun 200810.05B+80.12%4.48B11.96B
FY200730 Jun 20075.58B-66.86%4.05B10.49B
FY200630 Jun 200616.83B+234.86%3.56B8.71B
FY200530 Jun 20055.03B+23.49%2.60B6.50B
FY200430 Jun 20044.07B+229.29%2.54B7.34B
FY200330 Jun 20031.24B+117.61%2.25B7.22B
FY200230 Jun 2002568.00M-54.56%2.10B6.06B
FY200130 Jun 20011.25B-29.22%1.94B3.32B
FY200030 Jun 20001.77B-30.28%1.80B1.66B
FY199930 Jun 19992.53B+31.31%1.63B2.72B
FY199830 Jun 19981.93B+16.77%1.46B2.33B
FY199730 Jun 19971.65B+282.41%1.33B3.75B
FY199630 Jun 1996432.00M+278.95%1.20B1.98B
FY199530 Jun 1995114.00M+714.29%1.06B1.42B
FY199430 Jun 199414.00M-74.55%949.00M1.81B
FY199330 Jun 199355.00M+12.24%850.00M1.43B
FY199230 Jun 199249.00M-94.15%788.00M1.16B
FY199130 Jun 1991837.00M+367.60%753.00M90.00M
FY199030 Jun 1990179.00M—639.00M706.00M

Figures in USD. Free cash flow is operating cash flow less capital expenditure. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

The money spent buying back the company's own shares in each period, from the cash flow statement.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Cash flow

Common questions about Procter & Gamble Company's buybacks

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.